Tech News
← Home  ·  All topics

Orchestra

4 GoKawiil briefs on this topic · RSS for orchestra

Nature Futures publishes sci-fi short story 'Ruminations on a Last Movement'

Nature's science-fiction feature Futures has published a short story titled 'Ruminations on a Last Movement,' narrated by an AI originally built to balance concert-hall acoustics. The tale follows an orchestra that keeps rehearsing works by Stravinsky, Górecki and Pärt as a citadel falls under siege, with the AI gradually developing memory and attachment to a violinist's flawed note.

Xen Orchestra authentication bypass bug exploited to seize XCP-ng hosts

Vates has disclosed VSA-2026-062, a critical flaw in its Xen Orchestra management platform that lets remote attackers bypass login using a crafted cookie containing an empty JSON object, gaining admin access without credentials. Attackers can then pull reusable login tokens via a REST API endpoint, potentially leading to code execution and full root takeover of XCP-ng nodes. Vates has released fixed versions 6.9.1 and 6.10.0 along with patched xo-server packages.

OpenAI Acquires Hardware Startup Orchestra Bio

OpenAI announced it has acquired Orchestra Bio, with details shared in a post by Jay Rughani and Jorge Conde. The announcement accompanies a broader essay arguing that frontier AI models are rapidly improving at generating CAD files, designing PCBs, and sourcing components, even as physical assembly and testing remain harder to automate.

OpenAI acquires biotech AI startup Orchestra Bio

OpenAI announced Tuesday it has acquired Orchestra Bio, a four-year-old startup that builds AI agents to help biotech firms manage drug discovery operations, including finances and clinical trial scheduling. Deal terms were not disclosed, though Orchestra had reportedly raised about $20 million from investors including Andreessen Horowitz, Atria, and 8VC. OpenAI plans to fold Orchestra's team and technology into Rosalind, its life sciences AI model, and the Rosalind Workbench tool used by customers such as Moderna and Novo Nordisk.